Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 21;9(1):17307.
doi: 10.1038/s41598-019-53520-8.

Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia

Affiliations

Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia

Maja Oroz et al. Sci Rep. .

Abstract

Molecular epidemiology of HIV-1 infection in treatment-naive HIV-1 infected persons from Croatia was investigated. We included 403 persons, representing 92.4% of all HIV-positive individuals entering clinical care in Croatia in 2014-2017. Overall prevalence of transmitted drug resistance (TDR) was estimated at 16.4%. Resistance to nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside RTI (NNRTIs) and protease inhibitors (PIs) was found in 11.4%, 6.7% and 2.5% of persons, respectively. Triple-class resistance was determined in 2.2% of individuals. In addition, a single case (1.0%) of resistance to integrase strand-transfer inhibitors (InSTIs) was found. Deep sequencing was performed on 48 randomly selected samples and detected additional TDR mutations in 6 cases. Phylogenetic inference showed that 347/403 sequences (86.1%) were part of transmission clusters and identified forward transmission of resistance in Croatia, even that of triple-class resistance. The largest TDR cluster of 53 persons with T215S was estimated to originate in the year 1992. Our data show a continuing need for pre-treatment HIV resistance testing in Croatia. Even though a low prevalence of resistance to InSTI was observed, surveillance of TDR to InSTI should be continued.

PubMed Disclaimer

Conflict of interest statement

S.Z.L. received speaker’s honoraria and travel support from Gilead Sciences. M.L. received speaker’s honoraria and travel support from Gilead Sciences. Other authors declare that they have no competing financial and non-financial interests in relation to the work described.

Figures

Figure 1
Figure 1
Maximum likelihood phylogenetic analysis of the Croatian HIV-1 subtype B sequences from the old (2006–2008), the new (2014–2017) datasets and background sequences. Branches of Croatian sequences from the new dataset are coloured according to transmission risk: red, men who have sex with men (MSM); green, other. Branches of sequences from the old dataset are coloured blue, while branches of all background sequences are coloured black. All identified surveillance drug resistance mutations (SDRMs) are positioned on the tree along with the corresponding sequences. For SDRMs T215S; T215S + L210W; K101E; M41L + T215L; V32I + I47V + T215D/E + K103N + L100I (TRIPLE_CLASS_RES) that form local transmission clusters (TCs), above each cluster corresponding SDRMs were noted, meaning that all sequences inside TCs harbour SDRMs. TCs with >75% of Croatian sequences (local clusters) are highlighted blue, while TCs with <75% of Croatian sequences (mixed clusters) are highlighted yellow.
Figure 2
Figure 2
Bayesian maximum clade-credibility tree of the Croatian HIV-1 subtype B sequences from the new dataset (2014–2017) and corresponding background sequences. Branches are coloured according to the geographic origin, as presented on the legend of Fig. 2, with the exception of less frequent background sequences, which are coloured black. TCs with >75% of Croatian sequences (local clusters) are highlighted blue, while TCs with <75% of Croatian sequences (mixed clusters) are highlighted yellow. TCs with ≥5 Croatian sequences (Table 3) are marked on the sideward by ordinal numbers. The scale is set at 5-year intervals starting at the sampling time of the latest sequence (2017.91).

References

    1. Croatian National Institute of Public Health. Epidemiology of HIV-1 infection and AIDS in Croatia, https://www.hzjz.hr/sluzba-epidemiologija-zarazne-bolesti/epidemiologija... (2018).
    1. Begovac J, Zekan A, Skoko-Poljak D. Twenty years of human immunodeficiency virus infection in Croatia–an epidemic that is still in an early stage. Coll. Antropol. 2006;30:17–23. - PubMed
    1. Lantier JC, et al. A new human immunodeficiency virus derived from gorillas. Nat. Med. 2009;15:871–872. doi: 10.1038/nm.2016. - DOI - PubMed
    1. Sharp PM, et al. The origins of acquired immune deficiency syndrome viruses: where and when? Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2001;356:867–876. doi: 10.1098/rstb.2001.0863. - DOI - PMC - PubMed
    1. Los Alamos National Laboratory. HIV Circulating Recombinant Forms, https://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html (2019).

Publication types

Substances